Oliver Ashby’s Post

JLL’s new 2024 Life Sciences Real Estate Perspective is out now! Dive into current market dynamics, top clusters and future outlook for the Life Sciences sector.    From AI’s growing impact to biomanufacturing hotspots, get the insights you need to navigate the evolving Life Sciences landscape: https://lnkd.in/gmNGyg57 utm_source=linkedin&utm_medium=social&utm_campaign=am-us-bnd-res-bnd-tni-1024

What will matter most in the year ahead for Life Sciences? JLL's 2024 Life Sciences Trends to Watch report delves into six pivotal trends impacting the industry. From ecosystem dynamics to geographic influences, innovation advancements, and strategic partnerships, this report has it all. Explore the latest report: https://co.jll/491bpGW #JLLLifeSciences #2024trends #biopharma #medtech

Are you ready to dive into CRB's enlightening Horizons: Life Sciences 2023 report? Based on the views of 500+ industry leaders in North America and Europe, this report sheds light on the current state and prospects of the life science industry. Even amid industry turbulence, companies remain committed to mitigating risks and implementing strategic measures. What's particularly exciting is that 86% of respondents expect favorable business growth in the next three years, while only 1% anticipate a decline. Learn more about this dynamic industry's challenges, trends, and opportunities. Read on! #lifescience #industryinsights #growthpotential https://lnkd.in/gXWA4yau

Unlocking the Power of Subgroups in Clinical Trials Are you struggling to identify impactful patient subgroups for your clinical trials? They've tackled this challenge head-on!  Björn Bornkamp et. al. team conducted a data challenge with 100+ biostatisticians, analyzing 4 Phase III trials to predict treatment effects in a new population. Want to know the results and how we can help you? Let's connect! #datachallenge #clinicaltrials #biostatistics #subgroupidentification #pharma #datascience #healthcare #drugdevelopment Comment below with your biggest subgroup identification challenge, or DM me to learn more! https://lnkd.in/g2aaaA2i

Optimizing Patient Allocation in Platform Trials Platform trials are revolutionizing drug development, but optimizing patient allocation within their dynamic structure is a complex challenge. Marta Bofill Roig et. al. developed a novel approach to determine optimal allocation rates, considering factors like treatment arm changes and analysis strategy. Are you struggling with patient allocation in your platform trial? Let's connect! #platformtrials #clinicaltrials #drugdevelopment #biostatistics #datascience #optimization #healthcare" Share your challenges in the comments below or connect with us to discuss your specific needs. https://lnkd.in/g2aaaA2i

🚀 New Video Alert: Unlocking Market Access in Life Sciences 🚀 We are excited to announce the release of our latest video on YouTube, featuring the article "Unlocking Market Access in Life Sciences: Strategies for Navigating Regulatory, Pricing, and Reimbursement Challenges," prepared by Güvenç Koçkaya and Oznur Seyhun, and published by Market Access Today. In this video, we explore the critical aspects of market access in the life sciences industry. Learn about the essential strategies for overcoming regulatory, pricing, and reimbursement challenges to ensure healthcare products and services are accessible to those who need them. Key topics covered include: - What is Market Access in Life Sciences? - Regulatory Approval and Compliance - Effective Pricing Strategies - Securing Reimbursement - The Role of Health Economics and Outcomes Research (HEOR) - Patient Access and Stakeholder Engagement - Evidence Generation and Real-World Data This video is a must-watch for professionals in the healthcare and pharmaceutical industries who are looking to enhance their understanding of market access and its importance in bringing medical innovations to market. Watch the video now to gain valuable insights and stay ahead in the ever-evolving landscape of healthcare: https://lnkd.in/dnZD2ezk Don’t forget to like, comment, and subscribe to our channel for more informative content. Stay informed, stay ahead with Market Access Today: https://lnkd.in/d-cqnZY6 #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #pharmacoeconomics #health #pharmaceuticals #medicaldevices #genetherapies #celltherapies #diagnostics 

Unlocking the future of drug discovery: A data-driven approach to drug property prediction Struggling to choose the right method for drug property prediction? This new study sheds light on this challenge! Predicting drug properties is crucial for accelerating drug discovery and reducing costs. But with a vast array of methods and datasets, choosing the best approach can be overwhelming. The comprehensive analysis connects various datasets and methods, offering valuable insights for practitioners: Understanding property classes and datasets Importance of uncertainty quantification ⚖️ Balancing time and cost-effectiveness ⏰ Method selection based on data type (QSAR vs. ADMET) Key takeaway: There's no one-size-fits-all solution! The best method depends on the specific property and dataset. Connect with us: Let's discuss how to optimize drug property prediction for your needs! https://lnkd.in/g2aaaA2i

Each week we highlight five things affecting the life sciences industry. Here’s the latest.

Each week we highlight five things affecting the life sciences industry. Here’s the latest.

What macro forces are driving the life sciences industry forward?    That question is as important today as it's ever been. Our 2024 Life Sciences Real Estate Perspective and Cluster Analysis explores the top clusters and key drivers of growth amid a challenging market which is now beginning to show signs of positive momentum.   Explore where each market stacks up >> https://lnkd.in/eFdcj-K6